default author photo

Shun Lu

Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital

Shanghai

China

SCHOLARLY PAPERS

1

DOWNLOADS

129

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

HS-10296 – A Novel Third Generation EGFR Tyrosine Kinase Inhibitor: Results of the First-in-Human Phase 1 Trial in Patients with Previously Treated EGFR Mutant Advanced Non-Small-Cell Lung Cancer

Number of pages: 160 Posted: 12 Dec 2019
National Taiwan University - Department of Oncology, University of Colorado, Aurora, Chang Gung University - Chang Gung Memorial Hospital, Zhejiang University, Nanjing University of Chinese Medicine (NJUCM) - Jiangsu Province Hospital of Traditional Chinese Medicine, National Yang Ming University - Taipei Veterans General Hospital, Taichung Veterans General Hospital, Taipei Medical University, Huazhong University of Science and Technology - Tongji Medical College, Chang Gung Memorial Hospital - Division of Pulmonary and Critical Care Medicine, Beverly Hills Cancer Center, National Cheng Kung University - Department of Internal Medicine, Central South University - Department of Medical Oncology, Beijing Cancer Hospital, Beijing Cancer Hospital, Central South University - Hunan Cancer Hospital, University Cancer & Blood Center, LLC, Sichuan University - West China Hospital, Zhejiang University - Department of Medical Oncology, Pacific Cancer Medical Center, Inc., University of California, San Diego (UCSD), Dartmouth College - Dartmouth-Hitchcock Medical Center, University of Miami - Sylvester Comprehensive Cancer Center, University of Texas Medical Branch-Galveston, MultiCare Institute for Research and Innovation, Baptist Healthcare Systems, Inc., China Medical University, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital and Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital
Downloads 129 (561,789)

Abstract:

Loading...

epidermal growth factor receptor; mutated; non-small-cell lung cancer; phase 1 trial; safety